Search Within

Lale Kostakoglu

Formats
  1. Journal Article (15)
  2. Meeting Abstract (7)
Groups
  1. GSK Faculty (21)
  2. Molecular Imaging and Therapy Service (21)
  3. Molecular Pharmacology and Chemistry Program Faculty (21)
  4. Radiology, Department of (21)
  5. Sloan Kettering Institute Faculty (21)
  6. Department of Medicine (8)

More Groups

People
  1. Steven Larson (21)
  2. Chaitanya Divgi (7)
  3. Andrew Scott (6)
  4. Nai-Kong Cheung (6)
  5. Ronald Finn (6)
  6. Samuel Yeh (4)

More People

Years
  1. 2003 (1)
  2. 1996 (2)
  3. 1995 (4)
  4. 1994 (6)
  5. 1993 (3)
  6. 1992 (6)
Publications
  1. Journal of Nuclear Medicine (7)
  2. European Journal of Nuclear Medicine (5)
  3. Nuclear Medicine and Biology (3)
  4. Clinical Nuclear Medicine (2)
  5. Antibody, Immunoconjugates, and Radiopharmaceuticals (1)
  6. Cancer Investigation (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (7)
  2. Springer Verlag (5)
  3. Elsevier Science Inc. (3)
  4. Lippincott Williams & Wilkins (2)
  5. American Association for Cancer Research (1)
  6. Elsevier B.V. (1)

More Publishers

Results (22)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting metastatic prostate cancer with radiolabeled monoclonal antibody J591 to the extracellular domain of prostate specific membrane antigen
    Journal Article

    Bander, N. H.; Trabulsi, E. J.; Kostakoglu, L.; Yao, D.; Vallabhajosula, S.; Smith-Jones, P.; Joyce, M. A.; Milowsky, M.; Nanus, D. M.; Goldsmith, S. J.
    Journal of Urology (2003)

    Fulltext@MSK | Save
  • Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: Dosimetry calculations incorporating cross-organ beta doses
    Journal Article

    Ugur, O.; Kostakoglu, L.; Hui, E. T.; Fisher, D. R.; Garmestani, K.; Gansow, O. A.; Cheung, N. K. V.; Larson, S. M.
    Nuclear Medicine and Biology (1996)

    Fulltext@MSK | Save
  • Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: A pilot trial
    Journal Article

    Grant, S. C.; Kostakoglu, L.; Kris, M. G.; Yeh, S. D. J.; Larson, S. M.; Finn, R. D.; Oettgen, H. F.; Cheung, N. K. V.
    European Journal of Nuclear Medicine (1996)

    Fulltext@MSK | Save
  • Quantitative autoradiography to determine local GD(2) antigen concentration of a human neuroblastoma xenograft growing in nude mice using monoclonal antibody 3F8
    Journal Article

    Kostakoglu, L.; Ugur, O.; Cheung, N. K. V.; Zhang, J.; Huang, Y.; Larson, S. M.
    Antibody, Immunoconjugates, and Radiopharmaceuticals (1995)

    Fulltext@MSK | Save
  • Calculated and TLD-based absorbed dose estimates for I-131-labeled 3F8 monoclonal antibody in a human neuroblastoma xenograft nude mouse model
    Journal Article

    Ugur, O.; Scott, A. M.; Kostakoglu, L.; Hui, T. E.; Masterson, M. E.; Febo, R.; Sgouros, G.; Rosa, E.; Mehta, B. M.; Fisher, D. R.; more...
    Nuclear Medicine and Biology (1995)

    Fulltext@MSK | Save
  • Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma
    Journal Article

    Divgi, C. R.; Scott, A. M.; Dantis, L.; Capitelli, P.; Siler, K.; Hilton, S.; Finn, R. D.; Kemeny, N.; Kelsen, D.; Kostakoglu, L.; more...
    Journal of Nuclear Medicine (1995)

    Fulltext@MSK | Save
  • Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas
    Journal Article

    Kostakoglu, L.; Panicek, D. M.; Divgi, C. R.; Botet, J.; Healy, J.; Larson, S. M.; Abdel-Dayem, H. M.
    European Journal of Nuclear Medicine (1995)

    Fulltext@MSK | Save
  • Ga-66 citrate: A novel tumor localization agent for PET
    Meeting Abstract

    Kostakoglu, L.; Finn, R.; DiResta, G.; Pentlow, K.; Lee, J.; Mawlawi, O.; Larson, S. M.
    Proceedings of the American Association for Cancer Research Annual Meeting (1994)

    Fulltext@MSK | Save
  • Comparison of P-glycoprotein expression in cell lines and xenograft sections using I-125 MRK-16 monoclonal antibody (MAB)
    Meeting Abstract

    Mehta, B. M.; Kostakoglu, L.; Levchenko, A.; Broussard, E. L.; Divgi, C. R.; Zhang, J. J.; Scott, A. M.; Finn, R. D.; Biedler, J. L.; Tsuruo, T.; more...
    Journal of Nuclear Medicine (1994)

    Fulltext@MSK | Save
  • Phase II radioimmunotherapy (RIT) trial with I-131 labeled monoclonal antibody CC49 in TAG-72 expressing breast cancer
    Meeting Abstract

    Kostakoglu, L.; Divgi, C. R.; Gilewski, T.; Theodoulou, M.; Schlom, J.; Larson, S. M.
    Journal of Nuclear Medicine (1994)

    Fulltext@MSK | Save